High Morbidity Burden Borne Years Later by Survivors of Transplant

Helwick, Caroline
February 2012
American Health & Drug Benefits;Feb Special Issue 2012, Vol. 5, p22
Academic Journal
The article discusses research on hematopoietic cell transplant which was reported at a 2012 press conference by Stephanie J. Lee of the University of Washington School of Medicine in Seattle, Washington. The research found that while the transplants may cure many hematologic malignancies transplant recipients have an increased risk of chronic medical and psychological conditions.


Related Articles

  • Foscarnet vs ganciclovir for cytomegalovirus (CMV) antigenemia after allogeneic hemopoietic stem cell transplantation (HSCT): a randomised study. Moretti, S; Zikos, P; Van Lint, M T; Tedone, E; Occhini, D; Gualandi, F; Lamparelli, T; Mordini, N; Berisso, G; Bregante, S; Bruno, B; Bacigalupo, A // Bone Marrow Transplantation;7/15/98, Vol. 22 Issue 2, p175 

    This trial was designed to compare foscarnet with ganciclovir as pre-emptive therapy for CMV infection in patients undergoing allogeneic hemopoietic stem cell transplant (HSCT). Thirty-nine patients were randomized to receive foscarnet 90 mg/kg every 12 h (n = 20) or ganciclovir 5 mg/kg every 12...

  • Hematopoietic cell transplantation results in many late complications. Levitan, Dave // Hem/Onc Today;4/25/2009, Vol. 10 Issue 8, p1 

    This article reports on the emergence of late complications in some patients treatment with hematopoietic cell transplantation.

  • Risk factors identified for adenovirus infection in HSCT patients. Richards, Cassandra A. // Infectious Diseases in Children;Oct2012, Vol. 25 Issue 10, p11 

    The article presents information on research which examined the risk factors for adenovirus infection in children with hematopoietic stem cells transplant (HSCT).

  • Conservative management of pneumatosis intestinalis after allogeneic hematopoietic SCT. Bhamidipati, P K; Ghobadi, A; Bauer, S; DiPersio, J F; Pusic, I // Bone Marrow Transplantation;Nov2014, Vol. 49 Issue 11, p1436 

    A letter to the editor is presented which describes the management of pneumatosis intestinalis following allogeneic hematopoietic stem cell transplantation (SCT).

  • Late-onset hemorrhagic cystitis after hematopoietic stem cell transplantation in children. Kondo, M; Kojima, S; Kato, K; Matsuyama, T // Bone Marrow Transplantation;11/15/98, Vol. 22 Issue 10, p995 

    We analyzed the incidence, complications, and risk factors for late-onset hemorrhagic cystitis (HC) in 256 children undergoing hematopoietic stem cell transplantation (HSCT). Twenty-six recipients (10.2%) developed late-onset HC between 3 and 270 days (median, 33 days) after HSCT. In most...

  • Herpes zoster after autologous hematopoietic stem cell transplantation. dos Santos, Kelli Borges; e Souza, Rafaela Souto; Atalla, Angelo; Hallack-Neto, Abrahão Elias // Revista Brasileira de Hematologia e Hemoterapia;out-dez2016, Vol. 38 Issue 4, p298 

    Background: The autologous hematopoietic stem cell transplantation procedure involves immunosuppression of the patient. Thus, the patient has an elevated risk for several diseases, such as infections with the varicella-zoster virus. Prevention protocols have been proposed based on the use of...

  • Resetting the T Cell Compartment in Autoimmune Diseases With Autologous Hematopoietic Stem Cell Transplantation: An Update. Lutter, Lisanne; Spierings, Julia; van Rhijn-Brouwer, Femke C. C.; van Laar, Jacob M.; van Wijk, Femke // Frontiers in Immunology;4/20/2018, p1 

    Autologous hematopoietic stem cell transplantation (aHSCT) for autoimmune diseases has been applied for two decades as a treatment for refractory patients with progressive disease. The rationale behind aHSCT is that high-dose immunosuppression eliminates autoreactive T and B cells, thereby...

  • Adenovirus Infections in Hematopoietic Stem Cell Transplant Recipients. Howard, Dianna S.; Phillips II, Gordon L.; Reece, Donna E.; Munn, Riat K.; Henslee-Downey, Jean; Pittard, Melissa; Barker, Matthew; Pomeroy, Claire // Clinical Infectious Diseases;12/1/1999, Vol. 29 Issue 6, p1494 

    Discusses an incidence of adenovirus infections among recipients of hematopoietic stem cell transplant (HSCT) from January to March 1997. Comparison between recipients of allogeneic and autologous stem cells; Correlation between the isolation of adenovirus from more than 1 site and risk for...

  • Virological, Clinical, and Ophthalmologic Features of Cytomegalovirus Retinitis after Hematopoietic Stem Cell Transplantation. Crippa, Fulvio; Corey, Lawrence; Sale, George; Boeckh, Michael; Chuang, Elaine L. // Clinical Infectious Diseases;1/15/2001, Vol. 32 Issue 2, p214 

    Presents information on a study which examined the prevalence of cytomegalovirus retinitis in hematopoietic stem cell transplantation patients in Seattle, Washington. Methodology; Results of the study; Discussion.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics